Xu Juan, Chen Xiyi, Sun Yu, Shi Yaqian, Teng Fang, Lv Mingming, Liu Chen, Jia Xuemei
Deparment of Gynecology, Nanjing Maternity and Child Health Care Hospital, Women's Hospital of Nanjing Medical University, Nanjing, China.
Department of Breast, Nanjing Maternity and Child Health Care Hospital, Women's Hospital of Nanjing Medical University, Nanjing, China.
Front Oncol. 2021 Jul 9;11:691317. doi: 10.3389/fonc.2021.691317. eCollection 2021.
Breast cancer is one of the most common malignant tumors in women worldwide. Circular RNA (circRNA) is a class of structurally stable non-coding RNA with a covalently closed circular structure. In recent years, with the development of high-throughput RNA sequencing, many circRNAs have been discovered and have proven to be clinically significant in the development and progression of breast cancer. Importantly, several regulators of circRNA biogenesis have been discovered. Here, we systematically summarize recent progress regarding the network of regulation governing the biogenesis, degradation, and distribution of circRNAs, and we comprehensively analyze the functions, mechanisms, and clinical significance of circRNA in breast cancer.
乳腺癌是全球女性中最常见的恶性肿瘤之一。环状RNA(circRNA)是一类结构稳定的非编码RNA,具有共价闭合的环状结构。近年来,随着高通量RNA测序技术的发展,许多环状RNA被发现,并已证明在乳腺癌的发生和发展中具有临床意义。重要的是,已经发现了几种环状RNA生物合成的调节因子。在此,我们系统地总结了环状RNA生物合成、降解和分布调控网络的最新进展,并全面分析了环状RNA在乳腺癌中的功能、机制和临床意义。